Evidence map›Paper›PMID 40317445›Full record

ArticleJournal of nephrology2025

Metabolic dysregulation in regulatory T cells from patients with immune-mediated glomerular diseases.

Johan Noble, Zuzana Macek-Jilkova, Philippe Saas, Paolo Malvezzi, Miguel Fribourg, Leonardo V Riella, Mario Perez Arnedo, Joaquin Manrique, Paolo Cravedi

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Journal of nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Johan NoblePrecision Immunology Institute, Translational Transplant Research Center (TTRC), Icahn School of Medicine at Mount Sinai, One Gustave L Levy Place, Box 1243, New York, NY, 10029, USA.ORCID http://orcid.org/0000-0002-2329-0392
Zuzana Macek-JilkovaUniv. Grenoble Alpes, Inserm U 1209, CNRS UMR 5309, Team Cell Dynamics, Immunity, Metabolism & Cancer, Institute for Advanced Biosciences, Grenoble, France.ORCID http://orcid.org/0000-0002-2553-5971
Philippe SaasUniv. Grenoble Alpes, Inserm U 1209, CNRS UMR 5309, Team Cell Dynamics, Immunity, Metabolism & Cancer, Institute for Advanced Biosciences, Grenoble, France.ORCID http://orcid.org/0000-0002-8857-9939
Paolo MalvezziNephrology, Hemodialysis, Apheresis and Kidney Transplantation Department, University Hospital Grenoble, 38000, Grenoble, France.
Miguel FribourgPrecision Immunology Institute, Translational Transplant Research Center (TTRC), Icahn School of Medicine at Mount Sinai, One Gustave L Levy Place, Box 1243, New York, NY, 10029, USA.ORCID http://orcid.org/0000-0003-1804-8136
Leonardo V RiellaCenter for Transplantation Sciences, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-7636-3196
Mario Perez ArnedoNephrology Service, Hospital Universitario de Navarra, Pamplona, Spain.
Joaquin Manrique *Nephrology Service, Hospital Universitario de Navarra, Pamplona, Spain.
Paolo Cravedi *Precision Immunology Institute, Translational Transplant Research Center (TTRC), Icahn School of Medicine at Mount Sinai, One Gustave L Levy Place, Box 1243, New York, NY, 10029, USA. paolo.cravedi@mssm.edu.ORCID http://orcid.org/0000-0001-7837-0923

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40317445

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.